January 31, 2020
ARCH Venture Partners and Northpond Ventures are injecting $14 million into a Harvard team promising to visualize activity on a “subcellular level” — down to every RNA. Xiaowei Zhuang and David Walt are two of the prominent scientists behind Vizgen.